Cargando…

Oseltamivir resistance in swine influenza: a brief discussion

Swine flu, an atypical H1N1 influenza virus infection, is a new emerging infectious disease starting from Mexico in 2009, and is presently pandemic around the world. For treatment of this infection, oseltamivir is recommended as drug of choice. Generally, a big problem for using oseltamivir in treat...

Descripción completa

Detalles Bibliográficos
Autor principal: Wiwanitkit, Viroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364646/
https://www.ncbi.nlm.nih.gov/pubmed/22666678
_version_ 1782234572781518848
author Wiwanitkit, Viroj
author_facet Wiwanitkit, Viroj
author_sort Wiwanitkit, Viroj
collection PubMed
description Swine flu, an atypical H1N1 influenza virus infection, is a new emerging infectious disease starting from Mexico in 2009, and is presently pandemic around the world. For treatment of this infection, oseltamivir is recommended as drug of choice. Generally, a big problem for using oseltamivir in treatment of classical H1NI influenza virus infection is drug resistance. In this brief paper, the author discusses on the situation of oseltamivir resistance in swine influenza. Briefly, the oseltamivir resistance of swine flu is expected to be possible due to many underlying factors. It is needed to perform surveillance on oseltamivir resistance in swine flu. Planning for management of case of emerging oseltamivir drug resistance is needed.
format Online
Article
Text
id pubmed-3364646
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-33646462012-06-04 Oseltamivir resistance in swine influenza: a brief discussion Wiwanitkit, Viroj N Am J Med Sci Invited Article Swine flu, an atypical H1N1 influenza virus infection, is a new emerging infectious disease starting from Mexico in 2009, and is presently pandemic around the world. For treatment of this infection, oseltamivir is recommended as drug of choice. Generally, a big problem for using oseltamivir in treatment of classical H1NI influenza virus infection is drug resistance. In this brief paper, the author discusses on the situation of oseltamivir resistance in swine influenza. Briefly, the oseltamivir resistance of swine flu is expected to be possible due to many underlying factors. It is needed to perform surveillance on oseltamivir resistance in swine flu. Planning for management of case of emerging oseltamivir drug resistance is needed. Medknow Publications & Media Pvt Ltd 2009-08 /pmc/articles/PMC3364646/ /pubmed/22666678 Text en Copyright: © North American Journal of Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Invited Article
Wiwanitkit, Viroj
Oseltamivir resistance in swine influenza: a brief discussion
title Oseltamivir resistance in swine influenza: a brief discussion
title_full Oseltamivir resistance in swine influenza: a brief discussion
title_fullStr Oseltamivir resistance in swine influenza: a brief discussion
title_full_unstemmed Oseltamivir resistance in swine influenza: a brief discussion
title_short Oseltamivir resistance in swine influenza: a brief discussion
title_sort oseltamivir resistance in swine influenza: a brief discussion
topic Invited Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364646/
https://www.ncbi.nlm.nih.gov/pubmed/22666678
work_keys_str_mv AT wiwanitkitviroj oseltamivirresistanceinswineinfluenzaabriefdiscussion